<html>
<head>PUBMED IDs for HIST1H2BN</head>
<body bgcolor='#C5F0F2'><h1>HIST1H2BN</h1><a href='https://pubmed.ncbi.nlm.nih.gov/24256813/'>Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients.</a> December 15  2013<br></body></html>
